Simplified method of hepatic fibrosis quantification: Design of a new morphometric analysis application

Liver International

Volumn 25, Issue 6, 2005, Pages 1156-1161

  Friedenberg, Marc A ^a   Miller, Larry ^b   Chung, Chan Y ^b   Fleszler, Frederick ^b   Banson, Felice L ^b   Thomas, Rebecca ^b   Swartz, Kenneth P ^c   Friedenberg, Frank K ^b,d  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TEMPLE UNIVERSITY   (United States)

^d TEMPLE UNIVERSITY HOSPITAL   (United States)

Author keywords

Fibrosis; Image analysis; Software

Indexed keywords

ARTICLE; AUTOMATION; CALCULATION; COMPUTER PROGRAM; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LINEAR REGRESSION ANALYSIS; LIVER FIBROSIS; MORPHOMETRICS; QUANTITATIVE ANALYSIS; STANDARDIZATION;

AZO COMPOUNDS; BIOPSY, NEEDLE; COLORING AGENTS; EOSINE YELLOWISH-(YS); FIBROSIS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LIVER; LIVER CIRRHOSIS; METHYL GREEN; MICROSCOPY; SOFTWARE;

EID: 28944451519     PISSN: 14783223     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2005.01161.x     Document Type: Article

References (22)

1. Aube C, Oberti F, Korali N, Namour M A, Loisel D, Tanguy Jy, et al. Ultrasonographic diagnosis of hepatic fibrosis or cirrhosis. J Hepatol 1999; 30: 472-8.
2. Oberti F, Valsesia E, Pilette C, Rousselet M C, Bedossa P, Aube C, et al. Noninvasive diagnosis of hepatic fibrosis or cirrhosis. Gastroenterology 1997; 113: 1609-16.
3. Afdhal N H, Keaveny A P, Cohen S B, Nunes D P, Maldonado N, O'Brien M, et al. Urinary assays for desmosine and hydroxylslpyridinoloine in the detection of cirrhosis. J Hepatol 1997; 27: 993-1002.
4. Hui C K, Belaye T, Montegrande K, Wright T L. A comparison in the progression of liver fibrosis in chronic hepatitis C between persistently normal and elevated transaminase. J Hepatol 2003; 38: 511-7.
5. Knodell R G, Ishak K G, Black W C, Chen T S, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-5.
6. Ishak K, Baptista A, Bianchi L, Callea F, De Groof J, Gudat F, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-9.
7. The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994; 20: 15-20.
8. Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 1991; 13: 372-4.
9. Bedossa P, Bioulac-Sage P, Callard P. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994; 20: 15-20.
10. Carai A, Diaz G, Santa Cruz R, Santa Cruz G. Computerized quantitative color analysis for histological study of pulmonary fibrosis. Anticancer Res 2002; 22: 3889-94.
11. Kage M, Shimamatu K, Nakashima E, Kojiro M, Inove O, Yano M, et al. Long-term evolution of fibrosis from chronic hepatitis C: morphometric analysis of repeated biopsies. Hepatology 1997; 25: 1028-31.
12. Lin X Z, Horng M H, Sun Y N, Shiesh S C, Chow N H, Guo X Z, et al. Computer morphometry for quantitative measurement of liver fibrosis: comparison with Knodell's score, colorimetry and conventional description reports. J Gastroenterol Hepatol 1998; 13: 75-80.
13. O'Brien M J, Keating N M, Elderiny S, Cerda S, Keavney A P, Afdal N H, et al. An assessment of digital image analysis to measure fibrosis in liver biopsy specimens of patients with chronic hepatitis C. Am J Clin Pathol 2000; 114: 712-8.
14. Pilette C, Rousselet C, Bedossa P, Chappard D, Oberti F, Bifflet H, et al. Histopathological evaluation of liver fibrosis: quantitative image analysis vs semiquantitative scores. Comparison with serum markers. J Hepatol 1998; 28: 439-46.
15. Caballero T, Pérez-Milena A, Masseroli M, O'Valle F, Salmeron F J, Del Moral R G, et al. Liver fibrosis assessment with semiquantitative indexes and image analysis quantification in sustained-responder and non-responder interferon-treated patients with chronic hepatitis C. J Hepatol 2001; 34: 740-7.
16. Masseroli M, Caballero T, O'Valle F, Del Moral R M G, Perez-Milena A, Del MOral R G, et al. Autonomic quantification of liver fibrosis: design and validation of a new image analysis method. Comparison with semi-quantitative indexes of fibrosis. J Hepatol 2000; 32: 453-64.
17. Maduli E, Andorno S, Rigamonti C, Capelli F, Morelli S, Colombi S, et al. Evaluation of liver fibrosis in chronic hepatitis C with a computer-assisted morphometric method. Ann Ital Med Int 2002; 17: 242-7.
18. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997; 349: 825-32.
19. Persico M, Persico E, Suozzo R, Conte S, De Seta M, Coppola L, et al. Natural history of hepatitis C virus carriers with persistently normal aminotransferase levels. Gastroenterology 2000; 118: 760-4.
20. Camma C, Giunta M, Linea C, Pagliaro L. The effect of interferon on the liver in chronic hepatitis C: a quantitative evaluation of histology by meta-analysis. J Hepatol 1997; 26:1187-99.
21. Poynard T, McHutchinson J, Manns M, Trepo C, Lindsay K, Goodman Z, et al. Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. Gastroenterology 2002; 122: 1303-13.
22. Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003; 38: 1449-57.